Advanced Haemotechnologies
Country not established
- Devices
- 1
What Advanced Haemotechnologies makes
Advanced Haemotechnologies manufactures autologous blood collection sets, which are used to collect a patient’s own blood for transfusion or processing. The product is a sterile, single‑use system designed for intra‑operative or bedside blood collection.
The autologous blood collection set is classified as a Class II medical device and is listed in the FDA 510(k) database. Advanced Haemotechnologies is based in the United States.
Catalogue
Autologous Blood Collection Set Ref K923016
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Advanced Haemotechnologies have in the registry?
The registry currently lists 1 device for Advanced Haemotechnologies. Devices recorded under merged duplicate company entries are counted once.
Which registries list Advanced Haemotechnologies's devices?
Among its 1 most recently registered device, Advanced Haemotechnologies has devices listed in FDA 510(k) (1 device).
What risk classes do Advanced Haemotechnologies's devices fall under?
Among its 1 most recently registered device, the classes recorded for Advanced Haemotechnologies's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Advanced Haemotechnologies in the registry?
The most recently registered devices listed for Advanced Haemotechnologies include AUTOLOGOUS BLOOD COLLECTION SET.